新科学想法 学术文库 学术文献 浏览文献

有读书笔记Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells

唐唐 添加于 2011-2-7 05:55 | 1685 次阅读 | 0 个评论
  •  作 者

    Chen J, Wang L, Matyunina LV, Hill CG, McDonald JF
  •  摘 要

    Objective Ovarian cancer (OC) is the most lethal of all gynecological malignancies primarily due to the sloughing-off of highly metastatic cells from primary tumors and their subsequent spread throughout the peritoneal cavity. Since the epithelial-to-mesenchymal transition (EMT) of OC cells located at the periphery of primary tumors is essential to this process, molecular interventions that can block EMT are of potential clinical significance. Members of the miR200 family of microRNAs have been implicated in EMT in other cancers. Our purpose was to determine if miR200 family microRNAs may be involved in EMT in OC and of potential therapeutic value in reducing OC metastasis. Methods Gene expression profiles of two OC cell lines with different metastatic potentials were monitored using qRT-PCR (quantitative reverse transcription polymerase chain reaction). The effect of over-expression of a miR-200 family microRNA (miR-429) in metastatic OC cells was monitored on molecular (qRT-PCR and microarray) and functional (morphology, migration, invasiveness and anchorage independence assays) levels. Results Molecular profiling of two OC cell lines with differing metastatic potentials identified significant differences in previously established epithelial and mesenchymal cell biomarkers including E-cadherin, ZEB1, ZEB2, miR-205 and miR-200 family microRNAs. Ectopic overexpression of miR-429, a member of the miR-200 family of microRNAs, in mesenchymal-like OC cells resulted in reversal of the mesenchymal phenotype (mesenchymal–epithelial transition, MET). Conclusions Our results indicate that miR-429 may not only be a useful biomarker of EMT in ovarian cancer, but also of potential therapeutic value in abating OC metastasis.
  •  详细资料

    • 文献种类: Journal Article
    • 期刊名称: Gynecologic Oncology
    • 期刊缩写: Gynecologic Oncology
    • 期卷页: 2011
    • ISBN: 0090-8258
  • 学科领域 生物医药 » 生物学

  • 相关链接 DOI URL 

  •  唐唐 的文献笔记  订阅

    美科学家发现一种小核糖核酸有助治疗卵巢癌
    卵巢癌往往到晚期才被发现,而等到发现时,癌细胞已经转移到其他器官,难以通过化疗等方法治疗。美国最新研究发现,一种小核糖核酸可以有效对抗卵巢癌,这一发现将使医生有可能采用传统的化疗方法治疗卵巢癌。
     
    美国佐治亚理工学院的研究人员在美国新一期《妇科肿瘤学》杂志上报告说,他们在实验中利用具有调控功能的小核糖核酸-429,使卵巢癌细胞转变成不能转移的状态,从而使癌细胞无法扩散。
     
    负责这项研究的约翰·麦克唐纳指出,这一发现将使医生有可能将病人的癌细胞生命周期调回到可以采用传统的化疗方法治疗的阶段。
管理选项: 导出文献|

评论(0 人)

facelist doodle 涂鸦板

Copyright;  © 新科学想法 2016-2017   浙公网安备 33010202000686号   ( 浙ICP备09035230号-1 )